Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00813813 · ClinicalTrials.gov registry record · Phase 1
Intradiscal rhGDF-5 Phase I/II Clinical Trial
A Phase 1 study, sponsored by DePuy Spine.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT00813813 is a Phase 1 study that has completed, run by DePuy Spine. The registered enrollment target is 32 participants.
The verdict
NCT00813813, a Phase 1 study, has completed, sponsored by DePuy Spine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
Study to show the effectiveness and safety of a single injection of rhGDF5 into a degenerating single spinal disc in treating lumbar level degenerative disc disease
Interventions
- DRUG Intradiscal rhGDF-5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-06 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00813813
The ClinicalTrials.gov registry entry for NCT00813813 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DePuy Spine, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intradiscal rhGDF-5 is the first listed.
NCT00813813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00813813 about?
NCT00813813 is a clinical study titled "Intradiscal rhGDF-5 Phase I/II Clinical Trial". Study to show the effectiveness and safety of a single injection of rhGDF5 into a degenerating single spinal disc in treating lumbar level degenerative disc disease
What is the current status of trial NCT00813813?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2008-06. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00813813?
The interventions under investigation include: Intradiscal rhGDF-5 (DRUG).
Who is sponsoring clinical trial NCT00813813?
This trial is sponsored by DePuy Spine, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.